Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Assets Average: 2015-2025

Historic Assets Average for vTv Therapeutics (VTVT) over the last 10 years, with Sep 2025 value amounting to $63.0 million.

  • vTv Therapeutics' Assets Average rose 40.53% to $63.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.0 million, marking a year-over-year increase of 40.53%. This contributed to the annual value of $24.6 million for FY2024, which is 11.36% up from last year.
  • Latest data reveals that vTv Therapeutics reported Assets Average of $63.0 million as of Q3 2025, which was up 115.38% from $29.2 million recorded in Q2 2025.
  • vTv Therapeutics' 5-year Assets Average high stood at $63.0 million for Q3 2025, and its period low was $13.0 million during Q4 2023.
  • For the 3-year period, vTv Therapeutics' Assets Average averaged around $34.9 million, with its median value being $32.6 million (2024).
  • In the last 5 years, vTv Therapeutics' Assets Average slumped by 62.27% in 2023 and then soared by 213.89% in 2024.
  • Over the past 5 years, vTv Therapeutics' Assets Average (Quarterly) stood at $28.5 million in 2021, then increased by 20.82% to $34.4 million in 2022, then plummeted by 62.27% to $13.0 million in 2023, then soared by 213.89% to $40.7 million in 2024, then soared by 40.53% to $63.0 million in 2025.
  • Its last three reported values are $63.0 million in Q3 2025, $29.2 million for Q2 2025, and $35.1 million during Q1 2025.